A novel CDK4 inhibitor for myeloid protection in chemotherapy-treated triple-negative breast Cancer
{{output}}
Background: Despite advances in cancer treatment, chemotherapy remains a cornerstone of clinical practice. However, its efficacy is often compromised by dose-limiting haematologic toxicities. Recent strategies aim to enhance chem... ...
